project id: TCGA-SARC; case submitter id: TCGA-FX-A3TO; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 2.08; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; age at index: 87; days to birth: -31868; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1925; age at diagnosis: 31868; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 618.0; icd 10 code: C48.0; last known disease status: not reported; morphology: 8802/3; primary diagnosis: Giant cell sarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Retroperitoneum; synchronous malignancy: No; tissue or organ of origin: Retroperitoneum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 75; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-FX-A3TO-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;